Yuce Bio Snares ￥300M in Series C Financing

According to VCBeat, Shenzhen Yuce Biological Technology Co., Ltd. ("Yuce Bio") recently announced the completion of a ￥300 million Series C financing, led by Yuanzhi Science & Technology Medical, with participation from Puhua Capital. Probe Capital acted as the exclusive financial adviser. Proceeds from the latest round will be mainly used to expand the market, promote the application of products in tumor mutational burden (TMB) measurement, and establish a market-oriented clinical research service platform for companies of immunotherapy antibodies.

Founded in 2015, Yuce Bio is committed to solving the unmet needs of patients and drug firms in the field of tumor immunotherapy. The company has the first-class new antigen detection and identification platform, a professional database for cancer immunology based on bioinformatics, and the largest real-world research database of tumor Immunodiagnosis.

Relying on the international research and production system of high standards and its experienced management team, Yuce Bio provides clinical testing products for tumor patients and the development services of diagnostic biomarkers and therapeutic targets for pharmaceutical firms.

In terms of clinical business, Yuce Bio takes immunological diagnosis as one main business, targeted detection as the auxiliary; NGS as the main technology, supplemented by multi-platform of pathologic and cellular detection; and lung cancer as the main indication, and digestive tract tumors and other cancers with approved PD-1 /PD-L1 drugs as the auxiliary. The company has been widely recognized by clinicians in the past three years.

YuceOne Plus^®, the core product of Yuce Bio, is the first in vitro diagnostic reagent for comprehensive gene testing in China to assist oncologists to evaluate the effectiveness of the drug regimen for patients. The product has entered the key process of IVD application.

Puhua Capital is an equity investment firm that focuses on the early and middle project. The company provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.